Wang Hui, Sun Jia-Ying, Zhang Yue
Department of Rheumatology and Immunology, The First Affiliated Hospital of Harbin Medical University, Harbin 150001, Heilongjiang Province, China.
World J Psychiatry. 2024 Jun 19;14(6):866-875. doi: 10.5498/wjp.v14.i6.866.
Patients with ankylosing spondylitis (AS) frequently suffer from comorbid sleep disorders, exacerbating the burden of the disease and affecting their quality of life.
To investigate the clinical significance of serum inflammatory factors, health index and disease activity scores in patients with AS complicated by sleep disorders.
A total of 106 AS patients with comorbid sleep disorders were included in the study. The patients were grouped into the desirable and undesirable prognosis groups in accordance with their clinical outcomes. The serum levels of inflammatory factors, including C-reactive protein, erythrocyte sedimentation rate, interleukin (IL)-6, tumour necrosis factor-α and IL-1β, were measured. Disease activity scores, such as the Bath AS functional index, Bath AS disease activity index, Bath AS metrology index and AS disease activity score, were assessed. The health index was obtained through the Short Form-36 questionnaire.
The study found significant associations amongst serum inflammatory factors, health index and disease activity scores in AS patients with comorbid sleep disorders. Positive correlations were found between serum inflammatory factors and disease activity scores, indicating the influence of heightened systemic inflammation on disease severity and functional impairment. Conversely, negative correlations were found between disease activity scores and health index parameters, highlighting the effect of disease activity on various aspects of health-related quality of life. Logistic regression analysis further confirmed the predictive value of these factors on patient outcomes, underscoring their potential utility in risk assessment and prognostication.
The findings demonstrate the intricate interplay amongst disease activity, systemic inflammation and patient-reported health outcomes in AS patients complicated by sleep disorders. The results emphasise the need for comprehensive care strategies that address the diverse needs and challenges faced by these patients and underscore the potential relevance of serum inflammatory factors, health index and disease activity scores as prognostic markers in this patient population.
强直性脊柱炎(AS)患者常伴有睡眠障碍,加重了疾病负担,影响其生活质量。
探讨血清炎症因子、健康指数和疾病活动评分在合并睡眠障碍的AS患者中的临床意义。
本研究共纳入106例合并睡眠障碍的AS患者。根据临床结局将患者分为预后良好组和预后不良组。检测血清炎症因子水平,包括C反应蛋白、红细胞沉降率、白细胞介素(IL)-6、肿瘤坏死因子-α和IL-1β。评估疾病活动评分,如巴斯强直性脊柱炎功能指数、巴斯强直性脊柱炎疾病活动指数、巴斯强直性脊柱炎计量指数和强直性脊柱炎疾病活动评分。通过简短健康调查问卷(Short Form-36)获得健康指数。
研究发现,合并睡眠障碍的AS患者血清炎症因子、健康指数和疾病活动评分之间存在显著关联。血清炎症因子与疾病活动评分呈正相关,表明全身炎症加剧对疾病严重程度和功能损害有影响。相反,疾病活动评分与健康指数参数呈负相关,突出了疾病活动对健康相关生活质量各个方面的影响。逻辑回归分析进一步证实了这些因素对患者结局的预测价值,强调了它们在风险评估和预后判断中的潜在效用。
研究结果表明,在合并睡眠障碍的AS患者中,疾病活动、全身炎症和患者报告的健康结局之间存在复杂的相互作用。结果强调需要采取综合护理策略,以满足这些患者面临的各种需求和挑战,并强调血清炎症因子、健康指数和疾病活动评分作为该患者群体预后标志物的潜在相关性。